Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer

High-grade Bladder Cancer (BLCA) represents the most aggressive and treatment-resistant cancer that renders the patients with poor survival. However, only a few biomarkers have been identified for the detection and treatment of BLCA. Recent studies show that ganglioside GD2 can be used as cancer bio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Vantaku, Venkatrao, Donepudi, Sri Ramya, Ambati, Chandrashekar R., Jin, Feng, Putluri, Vasanta, Nguyen, Khoa, Rajapakshe, Kimal, Coarfa, Cristian, Battula, Venkata Lokesh, Lotan, Yair, Putluri, Nagireddy
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5707048/
https://ncbi.nlm.nih.gov/pubmed/29221154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21038
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak